CTNM Smart Money
Contineum Therapeutics, Inc.
1W: +6.3%
1M: -29.4%
3M: -37.5%
YTD: -21.1%
1Y: -18.6%
$8.99
+0.85 (+10.44%)
Weekly Expected Move ±23.0%
$4
$6
$8
$10
$12
Credit Risk of going bust: lower than 50% of companies Debt: 2.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.03 (down 99.6%), Contineum Therapeutics, Inc. would be worth roughly what it owes.
Total debt $6.6M against a stock market value of $296.3M.
Distance to default 5.16 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $3.3M (short-term plus half of long-term), stock volatility 82.7%; Altman Z'' 25.32. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.03 (down 99.6%), Contineum Therapeutics, Inc. would be worth roughly what it owes.
Total debt $6.6M against a stock market value of $296.3M.
Distance to default 5.16 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $3.3M (short-term plus half of long-term), stock volatility 82.7%; Altman Z'' 25.32. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026119
Institutions Holding
+18 vs prior
169.9%
Ownership
+35.59%
31
New
32
Increased
34
Reduced
15
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-08 | Stengone Carmine N. | officer: ceo and president | S-Sale | 2,500 | $16.46 | $41K | Filing |
| 2026-08-03 | Stengone Carmine N. | officer: ceo and president | S-Sale | 2,500 | $16.01 | $40K | Filing |
| 2026-07-09 | Lorrain Daniel S. | officer: chief scientific officer | S-Sale | 25 | $16.00 | $400 | Filing |
| 2026-07-08 | Lorrain Daniel S. | officer: chief scientific officer | S-Sale | 1,015 | $16.00 | $16K | Filing |
| 2026-07-08 | Stengone Carmine N. | officer: ceo and president | S-Sale | 2,500 | $16.00 | $40K | Filing |
| 2026-07-01 | Lorrain Daniel S. | officer: chief scientific officer | S-Sale | 2,501 | $16.24 | $41K | Filing |
| 2026-07-01 | Lorrain Daniel S. | officer: chief scientific officer | S-Sale | 5,852 | $15.67 | $92K | Filing |
| 2026-06-30 | Lorrain Daniel S. | officer: chief scientific officer | S-Sale | 28,826 | $16.04 | $462K | Filing |
| 2026-06-30 | Stengone Carmine N. | officer: ceo and president | S-Sale | 10,000 | $16.01 | $160K | Filing |
| 2026-06-30 | Watkins Tim | officer: cmo & head of development | S-Sale | 10,833 | $16.02 | $174K | Filing |
| 2026-06-01 | Lorrain Daniel S. | officer: chief scientific officer | S-Sale | 4,170 | $13.16 | $55K | Filing |
| 2026-05-01 | Lorrain Daniel S. | officer: chief scientific officer | S-Sale | 3,870 | $13.06 | $51K | Filing |
| 2026-05-01 | Lorrain Daniel S. | officer: chief scientific officer | S-Sale | 300 | $13.84 | $4K | Filing |
| 2026-04-06 | Lorrain Daniel S. | officer: chief scientific officer | S-Sale | 4,170 | $13.43 | $56K | Filing |
| 2026-03-02 | Lorrain Daniel S. | officer: chief scientific officer | S-Sale | 4,170 | $15.01 | $63K | Filing |
| 2026-03-02 | Watkins Tim | officer: cmo & head of development | S-Sale | 3,611 | $15.02 | $54K | Filing |
| 2026-02-25 | Stengone Carmine N. | officer: ceo and president | S-Sale | 2,700 | $16.02 | $43K | Filing |
| 2026-02-25 | Lorrain Daniel S. | officer: chief scientific officer | S-Sale | 3,824 | $16.01 | $61K | Filing |
| 2026-02-24 | Stengone Carmine N. | officer: ceo and president | S-Sale | 4,400 | $16.02 | $70K | Filing |
| 2026-02-24 | Lorrain Daniel S. | officer: chief scientific officer | S-Sale | 4,300 | $16.03 | $69K | Filing |
| 2026-02-19 | Lorrain Daniel S. | officer: chief scientific officer | S-Sale | 100 | $16.00 | $2K | Filing |
| 2026-02-11 | Stengone Carmine N. | officer: ceo and president | S-Sale | 400 | $16.00 | $6K | Filing |
| 2026-02-11 | Lorrain Daniel S. | officer: chief scientific officer | S-Sale | 400 | $16.00 | $6K | Filing |
| 2026-02-03 | Lorrain Daniel S. | officer: chief scientific officer | S-Sale | 1,170 | $15.25 | $18K | Filing |
| 2026-02-03 | Lorrain Daniel S. | officer: chief scientific officer | S-Sale | 3,000 | $14.82 | $44K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | 2,841,334 | $47M | — | 2026-06-30 | Filing |
| Jupiter Topco LLC | 2,734,836 | $45M | +2,734,836 | 2026-06-30 | Filing |
| BlackRock, Inc. | 2,064,345 | $34M | +1,395,222 | 2026-06-30 | Filing |
| JOHNSON & JOHNSON | 1,979,173 | $32M | — | 2026-06-30 | Filing |
| FRANKLIN RESOURCES INC | 1,839,227 | $30M | — | 2026-06-30 | Filing |
| Balyasny Asset Management L.P. | 1,522,793 | $25M | -162,842 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,321,356 | $22M | +107,183 | 2026-06-30 | Filing |
| PERCEPTIVE ADVISORS LLC | 1,255,592 | $21M | — | 2026-06-30 | Filing |
| FMR LLC | 1,040,130 | $17M | +225,259 | 2026-06-30 | Filing |
| MILLENNIUM MANAGEMENT LLC | 931,709 | $15M | -603,740 | 2026-06-30 | Filing |
| GREAT POINT PARTNERS LLC | 921,481 | $15M | +121,283 | 2026-06-30 | Filing |
| Longaeva Partners L.P. | 812,757 | $13M | +80,669 | 2026-06-30 | Filing |
| Ikarian Capital, LLC | 807,874 | $13M | — | 2026-06-30 | Filing |
| SECTORAL ASSET MANAGEMENT INC | 727,587 | $12M | — | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 693,188 | $11M | +411,150 | 2026-06-30 | Filing |
| HHLR ADVISORS, LTD. | 669,337 | $11M | — | 2026-06-30 | Filing |
| RED TREE MANAGEMENT, LLC | 638,158 | $10M | — | 2026-06-30 | Filing |
| Versant Venture Management, LLC | 542,628 | $9M | — | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 497,255 | $8M | +190,147 | 2026-06-30 | Filing |
| Boxer Capital Management, LLC | 494,000 | $8M | — | 2026-06-30 | Filing |